Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Legha

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Cancer|August 1, 1980
Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapyS S Legha, A U Buzdar, T L Smith, et al.
Cancer|January 15, 1980
Pulmonary toxicity of mitomycinA U Buzdar, S S Legha, M A Luna, et al.
Cancer|January 28, 1998
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2I I Raad, R Y Hachem, D Abi-Said, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicityS S Legha, Y M Wang, B Mackay, et al.
Anti-Cancer Drugs|November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanomaA Y Bedikian, S S Legha, O Eton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules S S Legha, N E Papadopoulos, C Plager, et al.
Cancer Treatment Reports|March 1, 1986
Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomasJ A Ajani, I Dimery, S P Chawla, et al.
Cancer Treatment Reports|February 1, 1984
Phase II study of PCNU in the treatment of head and neck carcinomaI W Dimery, S S Legha, W K Murphy, et al.
Cancer|November 1, 1995
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factorsA Y Bedikian, S S Legha, G Mavligit, et al.
Cancer Research|November 1, 1978
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivativeS S Legha, J U Gutterman, S W Hall, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Cancer|August 1, 1980
Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapyS S Legha, A U Buzdar, T L Smith, et al.
Cancer|January 15, 1980
Pulmonary toxicity of mitomycinA U Buzdar, S S Legha, M A Luna, et al.
Cancer|January 28, 1998
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2I I Raad, R Y Hachem, D Abi-Said, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicityS S Legha, Y M Wang, B Mackay, et al.
Anti-Cancer Drugs|November 26, 1999
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanomaA Y Bedikian, S S Legha, O Eton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules S S Legha, N E Papadopoulos, C Plager, et al.
Cancer Treatment Reports|March 1, 1986
Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomasJ A Ajani, I Dimery, S P Chawla, et al.
Cancer Treatment Reports|February 1, 1984
Phase II study of PCNU in the treatment of head and neck carcinomaI W Dimery, S S Legha, W K Murphy, et al.
Cancer|November 1, 1995
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factorsA Y Bedikian, S S Legha, G Mavligit, et al.
Cancer Research|November 1, 1978
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivativeS S Legha, J U Gutterman, S W Hall, et al.
Pageof 18